Can you provide a detailed explanation of the female menstrual cycle?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

The Female Menstrual Cycle: A Detailed Explanation

Overview and Duration

The menstrual cycle is a coordinated hormonal process lasting 21-35 days (average 28 days) that prepares the female reproductive system for pregnancy through integrated actions of the hypothalamus, pituitary gland, ovaries, and uterus. 1, 2

The cycle exhibits high variability in length between women and even cycle-to-cycle in the same woman, with typical menstrual bleeding lasting 5 days. 2

Hormonal Control: The Hypothalamic-Pituitary-Ovarian Axis

The Hypothalamic Pulse Generator

  • The hypothalamus acts as the cycle's metronome, releasing gonadotropin-releasing hormone (GnRH) in pulsatile fashion. 3
  • GnRH pulses occur every 1-1.5 hours during the follicular phase and slow to every 2-4 hours during the luteal phase. 3
  • This pulsatile pattern is essential—continuous GnRH would paradoxically suppress the system. 3

Pituitary Response

  • Pulsatile GnRH stimulates the anterior pituitary to secrete two key gonadotropins: follicle-stimulating hormone (FSH) and luteinizing hormone (LH). 3
  • The pituitary translates hypothalamic signals into hormones that the ovarian follicles can respond to. 3

The Four Phases of the Menstrual Cycle

Phase 1: Menstrual Phase (Days 1-5)

  • Day 1 is defined as the first day of menstrual bleeding. 2
  • Menstruation represents shedding of the functional endometrial layer in the absence of pregnancy. 2
  • This process is initiated by progesterone-responsive decidual cells and executed through prostaglandins (PGE and PGF2α), vasoconstriction, and matrix metalloprotease secretion by leukocytes. 2
  • The endometrium breaks down as progesterone and estradiol levels fall, triggering an inflammatory-like response. 4

Phase 2: Follicular Phase (Days 1-14, Variable Length)

Early Follicular Phase (Days 1-7):

  • FSH rises at the luteal-follicular transition, stimulating a cohort of follicles to begin growing. 2
  • Baseline FSH and LH measurements taken between days 3-6 provide the most accurate assessment of ovarian reserve (calculated as average of three measurements taken 20 minutes apart). 1, 5
  • Growing follicles secrete inhibin B, which provides negative feedback to reduce FSH levels. 2
  • Normal early follicular FSH should be <10 IU/L; levels >35 IU/L suggest ovarian failure. 1, 5

Mid-Follicular Phase (Days 7-10):

  • One follicle becomes dominant (the "dominant follicle" or DF) through superior FSH responsiveness, IGF binding protein expression, and enhanced vascularization. 2
  • The dominant follicle increasingly secretes estradiol as it grows, while other follicles undergo atresia (programmed cell death). 2, 6
  • Two-thirds of women show two follicle waves per cycle, while one-third show three waves; three-wave women have longer cycles. 2

Late Follicular Phase (Days 10-14):

  • The dominant follicle grows rapidly and secretes increasing amounts of estradiol and inhibin A for approximately one week before ovulation. 2
  • Theca cells (stimulated by LH) produce androstenedione, which granulosa cells (stimulated by FSH) convert to estradiol via aromatase enzyme. 3
  • Rising estradiol initially suppresses LH and FSH through negative feedback. 3

Phase 3: Ovulation (Day 14, Variable)

The LH Surge:

  • When estradiol reaches a critical threshold (sustained levels >200 pg/mL for 48+ hours), it switches from negative to positive feedback. 3
  • This triggers a massive LH surge (and smaller FSH surge) through the kisspeptin system in the hypothalamus. 3
  • The LH surge typically occurs 24-36 hours before ovulation. 7

Follicle Rupture:

  • The LH surge initiates the ovulation process, causing the mature follicle (typically 18-25mm) to rupture and release the oocyte. 3
  • Ovulation generally occurs on days 9-20 of the cycle, depending on cycle length. 8
  • For a standard 28-day cycle, ovulation occurs around day 14; for shorter 25-day cycles, it occurs around days 11-12. 7

Fertile Window:

  • The fertile period spans 5 days before ovulation through the day of ovulation. 2
  • Sperm can survive up to 5 days in the female reproductive tract, while the oocyte remains viable for 12-24 hours after ovulation. 7

Phase 4: Luteal Phase (Days 15-28, Fixed Duration)

Corpus Luteum Formation:

  • After ovulation, the ruptured follicle transforms into the corpus luteum ("yellow body"). 3
  • The corpus luteum secretes progesterone, estradiol, and inhibin A in response to LH pulses. 2
  • Peak corpus luteum function occurs 6-7 days after ovulation (around day 21 in a 28-day cycle). 2

Progesterone Dominance:

  • Progesterone levels rise dramatically, reaching peak levels in the mid-luteal phase. 3
  • Progesterone prepares the endometrium for implantation and suppresses the inflammatory response that would otherwise reject an embryo. 3, 4
  • Mid-luteal progesterone ≥6 nmol/L (≥5 ng/mL) confirms ovulation occurred; levels <6 nmol/L indicate anovulation. 1, 8

Luteal Regression or Rescue:

  • The corpus luteum has a fixed lifespan of approximately 14 days unless rescued by human chorionic gonadotropin (hCG) from an implanting embryo. 2
  • Without pregnancy, the corpus luteum passively regresses, causing progesterone and estradiol to fall. 2
  • Falling hormone levels trigger menstruation and allow FSH to rise, initiating the next cycle. 2

Endometrial Changes Throughout the Cycle

Proliferative Phase (Corresponds to Follicular Phase)

  • Rising estradiol stimulates endometrial proliferation and thickening. 3
  • The functional endometrial layer regenerates after menstruation. 2
  • Endometrial glands elongate and blood vessels proliferate. 9

Secretory Phase (Corresponds to Luteal Phase)

  • Progesterone transforms the proliferative endometrium into secretory tissue. 3
  • Endometrial glands become tortuous and begin secreting glycogen-rich fluid. 9
  • The endometrium becomes optimally receptive for embryo implantation during the mid-luteal phase (days 19-23). 3
  • Specific implantation markers (such as integrins) are expressed during this "window of implantation." 6

Cervical and Tubal Changes

  • Cervical mucus changes throughout the cycle: thick and impenetrable during most of the cycle, becoming thin, clear, and stretchy ("spinnbarkeit") around ovulation to facilitate sperm transport. 9
  • The uterine tubes undergo cyclical changes in ciliary activity and secretions to support oocyte and embryo transport. 9

Normal Hormonal Values and Patterns

Early Follicular Phase (Days 3-6):

  • FSH: <10 IU/L (normal ovarian reserve); >35 IU/L suggests ovarian failure 1, 5
  • LH: <7 IU/mL may indicate hypothalamic dysfunction; >11 IU/L may suggest ovarian failure 1
  • LH:FSH ratio: Should be <2; ratio >2 suggests PCOS 1
  • Estradiol: Low baseline levels 5

Mid-Cycle (Ovulation):

  • LH surge: Dramatic rise, typically 2-3 times baseline 3
  • Estradiol: Peak levels >200 pg/mL 3

Mid-Luteal Phase (Day 21 in 28-day cycle):

  • Progesterone: ≥6 nmol/L (≥5 ng/mL) confirms ovulation 1, 8
  • Estradiol: Secondary rise 2

Common Abnormalities and Pitfalls

Anovulation

  • Anovulation (failure to ovulate) can occur despite regular bleeding patterns. 1
  • Common causes include polycystic ovary syndrome (PCOS), hypothalamic amenorrhea, hyperprolactinemia, and thyroid disorders. 1
  • PCOS affects 4-6% of women generally but 10-25% of women with temporal lobe epilepsy, characterized by LH:FSH ratio >2, hyperandrogenism, and chronic anovulation. 1

Timing Errors in Hormone Assessment

  • Hormone measurements must occur at specific cycle points: FSH/LH on days 3-6, progesterone 7 days post-ovulation (approximately day 21 for 28-day cycles). 1, 5, 8
  • For irregular cycles, progesterone should be measured approximately 7 days before expected menses, not automatically on day 21. 8
  • Hormonal contraceptives must be discontinued at least 2 months before testing to allow normal pituitary-ovarian axis function to return. 5

Luteal Phase Defects

  • Inadequate progesterone production can prevent successful implantation even if ovulation occurs. 8
  • This requires mid-luteal progesterone measurement, not just confirmation of ovulation. 8

Energy Deficiency in Athletes

  • Female athletes are at high risk (47.3%) for low energy availability, which can disrupt the menstrual cycle. 1
  • Energy availability should be ≥45 kcal·kg⁻¹ fat-free mass·day⁻¹ for optimal reproductive function. 1
  • Common micronutrient deficiencies (iron, vitamin D, calcium) can further impact menstrual health. 1

Clinical Implications

Contraception Timing

  • Combined hormonal contraceptives can be started at any time if pregnancy is reasonably excluded, though backup contraception is needed for 7 days if started >5 days after menstrual bleeding begins. 1
  • Understanding the fertile window is crucial for both achieving and avoiding pregnancy. 7, 2

Fertility Assessment

  • Normal baseline hormones (FSH, LH, estradiol) do not guarantee ovulation; mid-luteal progesterone measurement is essential for confirmation. 5
  • Women with regular cycles can still be anovulatory, requiring hormonal documentation. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The normal menstrual cycle in women.

Animal reproduction science, 2011

Research

The endocrinology of the menstrual cycle.

Methods in molecular biology (Clifton, N.J.), 2014

Research

Menstruation: a nonadaptive consequence of uterine evolution.

The Quarterly review of biology, 1998

Guideline

Hormonal Indicators of Ovulation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Regulation of the human menstrual cycle.

Frontiers in neuroendocrinology, 1998

Guideline

Optimal Fertilization Timing

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Day 21 Progesterone Level as an Indicator of Ovulation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.